+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Test Type (Antibody Tests, Viral Load Tests), By Mode (Self-Test, Lab-based), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893284
Description Jump to:
The global HIV diagnostics market is expected to reach USD 1550.17 million by 2030, growing at an estimated CAGR of 5.5% from 2023 to 2030. Key factors accounting for the growth of this market include the growing need in for the development of more sensitive HIV diagnostic point of care tests which can be easily implemented at the location of patient care in resource-limited settings. Technological development of tests which is expected to introduce a number of novel rapid, point-of-care tests throughout the forecast period is a primary factor expected to fuel the growth of the HIV diagnostics market. Furthermore, government programs and campaigns initiated against HIV, global healthcare efforts to reduce disease incidence, and the presence of high unmet demand in the Middle Eastern and Eastern regions of the market are some key factors expected to serve as lucrative future growth opportunities.

HIV Diagnostics Market Report Highlights

  • The antibody test type segment dominated the industry and accounted for the largest revenue share of 53.3% in 2022. This large share can be accounted for by the high market usage and penetration rates of these tests which include, ELISA, home access dried blood spot, western blot testing IFA, and RIPA. These tests are highly sensitive and accurate and thus are most commonly used for screening and confirmation of HIV-1 & HIV-2.
  • Viral Load testing and CD4 testing also accounted for a considerable share of the market in 2022. There is a prevalent in the market for the development of these tests which will make them more sensitive, rapid in nature, and portable to the point of care to enhance their market usability and accessibility in resource-limited HIV-affected regions.
  • It is expected that during the forecast period, a number of novel point-of-care HIV diagnostic products will be commercialized which are currently under clinical development and in product pipelines of key market players. This increase in the range of products is expected to fuel the growth of this market over the forecast period.
  • Asia Pacific dominated the market and accounted for the largest revenue share of 35.7% in 2022 owing to technological advancement, an increase in the number of people suffering from HIV and AIDS, and increasing awareness regarding the same in this region.
  • Latin America is expected to grow at the fastest CAGR of 6.9% during the forecast period owing to the increasing awareness about diagnostic testing in the region.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Mode
1.1.3. Test type
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Mode outlook
2.2.3. Test type
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. HIV Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. HIV Diagnostics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. HIV Diagnostics Market: Product Estimates & Trend Analysis
4.1. HIV Diagnostics Market Key Takeaways
4.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Consumables
4.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments test market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Software And Services
4.5.1. Software and services market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. HIV Diagnostics Market: Mode Estimates & Trend Analysis
5.1. HIV Diagnostics Market Key Takeaways
5.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Self-Test
5.3.1. Self-test market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Lab-Based
5.4.1. Lab-based market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. HIV Diagnostics Market: Test Type Estimates & Trend Analysis
6.1. HIV Diagnostics Market Key Takeaways
6.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Antibody Test
6.3.1. Antibody test market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.1. HIV -1 screening market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.1.1. ELISA/EIA market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.1.2. Home access dried blood spot market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.1.3. Rapid tests (Dot plot, Agglutination tests) market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.2. HIV-1 antibody confirmatory tests
6.3.1.2.1. Western blot test market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.2.2. Indirect Immunofluorescent Antibody Assay (IFA) market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.2.3. Line immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.2.4. RadioImmunoPrecipitation Assay (RIPA) market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.3. HIV-2 and group O diagnostic tests
6.3.1.3.1. Blood antibody tests market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.3.2. Dried Blood Spot (DBS) test market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.1.3.3. Others (Oral, Urine) market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Viral Load Test
6.4.1. Viral load test market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. CD4 Test
6.5.1. CD4 test market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. HIV Diagnostics Market: End-use Estimates & Trend Analysis
7.1. HIV Diagnostics Market: Key Takeaways
7.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Diagnostic Laboratories
7.3.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Hospitals & Clinics
7.4.1. Hospitals & Clinics Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5. Home Settings
7.5.1. Home settings market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. HIV Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. HIV Diagnostics Market by Region: Key Marketplace Takeaway
8.3. North America
8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. Alere Inc.
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Abbott.
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Bristol-Myers Squibb Company
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Janssen Global Service, LLC
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Gilead Sciences, Inc.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Merck & Co. Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. VIIV Healthcare
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. BD
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Beckman Coulter, Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Sysmex Europe SE
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. Apogee Flow Systems
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
9.2.12. Point Care Technologies Inc.
9.2.12.1. Company overview
9.2.12.2. Financial performance
9.2.12.3. Product benchmarking
9.2.12.4. Strategic initiatives
9.2.13. Mylan N.V.
9.2.13.1. Company overview
9.2.13.2. Financial performance
9.2.13.3. Product benchmarking
9.2.13.4. Strategic initiatives
9.2.14. F. Hoffman-La Roche Ltd.
9.2.14.1. Company overview
9.2.14.2. Financial performance
9.2.14.3. Product benchmarking
9.2.14.4. Strategic initiatives
9.2.15. Siemens Healthcare GmbH
9.2.15.1. Company overview
9.2.15.2. Financial performance
9.2.15.3. Product benchmarking
9.2.15.4. Strategic initiatives
9.2.16. QIAGEN.
9.2.16.1. Company overview
9.2.16.2. Financial performance
9.2.16.3. Product benchmarking
9.2.16.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 North America HIV diagnostics market by mode, 2018 - 2030 (USD Million)
Table 4 North America HIV diagnostics Market by test type, 2018 - 2030 (USD Million)
Table 5 North America HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 6 North America HIV diagnostics market by region, 2018 - 2030 (USD Million)
Table 7 U.S. HIV diagnostics Market by product, 2018 - 2030 (USD Million)
Table 8 U.S. HIV diagnostics market by mode, 2018 - 2030 (USD Million)
Table 9 U.S. HIV diagnostics Market by test type, 2018 - 2030 (USD Million)
Table 10 U.S. HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada HIV diagnostics market by product, 2018 - 2030 (USD Million)
Table 12 Canada HIV diagnostics market by mode, 2018 - 2030 (USD Million)
Table 13 Canada. HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 14 Canada HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe HIV diagnostics market by product, 2018 - 2030 (USD Million)
Table 16 Europe HIV diagnostics market by mode, 2018 - 2030 (USD Million)
Table 17 Europe HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 18 Europe HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe HIV diagnostics market, by region, 2018 - 2030 (USD Million)
Table 20 Germany HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 21 Germany HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 22 Germany HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 23 Germany HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 24 UK HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 25 UK HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 26 UK HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 27 UK HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 28 France HIV diagnostics market, by type, 2018 - 2030 (USD Million)
Table 29 France HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 30 France HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 31 France HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 32 Italy HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 33 Italy HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 34 Italy HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 35 Italy HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 36 Spain HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 37 Spain HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 38 Spain HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 39 Spain HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 40 Sweden HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 41 Sweden HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 42 Sweden HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 43 Sweden HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 44 Norway HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 45 Norway HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 46 Norway HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 47 Norway HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 48 Denmark HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 49 Denmark HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 50 Denmark HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 51 Denmark HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 52 Asia Pacific HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 53 Asia Pacific HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 54 Asia Pacific HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 55 Asia Pacific HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 56 Asia Pacific HIV diagnostics market, by region, 2018 - 2030 (USD Million)
Table 57 China HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 58 China HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 59 China. HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 60 China HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 61 Japan HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 62 Japan HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 63 Japan HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 64 Japan HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 65 India HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 66 India HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 67 India HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 68 India HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 69 Australia HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 70 Australia HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 71 Australia HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 72 Australia HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 73 Thailand HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 74 Thailand HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 75 Thailand HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 76 Thailand HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 77 South Korea HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 78 South Korea HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 79 South Korea HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 80 South Korea HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 81 Latin America HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 82 Latin America HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 83 Latin America HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 84 Latin America HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 85 Latin America HIV diagnostics market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 87 Brazil HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 88 Brazil HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 89 Brazil HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 90 Mexico HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 91 Mexico HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 92 Mexico HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 93 Mexico HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 94 Argentina HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 95 Argentina HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 96 Argentina HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 97 Argentina HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa HIV diagnostics market, by region, 2018 - 2030 (USD Million)
Table 103 South Africa HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 104 South Africa HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 105 South Africa HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 106 South Africa HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 111 UAE HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 112 UAE HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 113 UAE HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 114 UAE HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 115 Kuwait HIV diagnostics market, by product, 2018 - 2030 (USD Million)
Table 116 Kuwait HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
Table 117 Kuwait HIV diagnostics market by test type, 2018 - 2030 (USD Million)
Table 118 Kuwait HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 HIV diagnostics: Market outlook
Fig. 9 HIV diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 HIV diagnostics market driver impact
Fig. 15 HIV diagnostics market restraint impact
Fig. 16 HIV diagnostics market strategic initiatives analysis
Fig. 17 HIV diagnostics market: Product movement analysis
Fig. 18 HIV diagnostics market: Product outlook and key takeaways
Fig. 19 Consumables market estimates and forecasts, 2018 - 2030
Fig. 20 Instruments market estimates and forecasts, 2018 - 2030
Fig. 21 Software and services market estimates and forecasts, 2018 - 2030
Fig. 22 HIV diagnostics market: Mode movement analysis
Fig. 23 HIV diagnostics market: Mode outlook and key takeaways
Fig. 24 Self-test market estimates and forecasts, 2018 - 2030
Fig. 25 Lab-based market estimates and forecasts, 2018 - 2030
Fig. 26 HIV diagnostics market: Test type movement analysis
Fig. 27 HIV diagnostics market: Test type outlook and key takeaways
Fig. 28 Antibody test market estimates and forecasts, 2018 - 2030
Fig. 29 Viral load test market estimates and forecasts, 2018 - 2030
Fig. 30 CD4 test market estimates and forecasts, 2018 - 2030
Fig. 31 Other market estimates and forecasts, 2018 - 2030
Fig. 32 HIV diagnostics market: End-use movement analysis
Fig. 33 HIV diagnostics market: End-use outlook and key takeaways
Fig. 34 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
Fig. 35 Hospitals & clinics market estimates and forecasts, 2018 - 2030
Fig. 36 Home settings market estimates and forecasts, 2018 - 2030
Fig. 37 Other market estimates and forecasts, 2018 - 2030
Fig. 38 Global HIV diagnostics market: Regional movement analysis
Fig. 39 Global HIV diagnostics market: Regional outlook and key takeaways
Fig. 40 North America market estimates and forecasts, 2018 - 2030
Fig. 41 U.S. market estimates and forecasts, 2018 - 2030
Fig. 42 Canada market estimates and forecasts, 2018 - 2030
Fig. 43 Europe. market estimates and forecasts, 2018 - 2030
Fig. 44 UK market estimates and forecasts, 2018 - 2030
Fig. 45 Germany market estimates and forecasts, 2018 - 2030
Fig. 46 France market estimates and forecasts, 2018 - 2030
Fig. 47 Italy market estimates and forecasts, 2018 - 2030
Fig. 48 Spain market estimates and forecasts, 2018 - 2030
Fig. 49 Sweden market estimates and forecasts, 2018 - 2030
Fig. 50 Norway market estimates and forecasts, 2018 - 2030
Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 53 Japan market estimates and forecasts, 2018 - 2030
Fig. 54 China market estimates and forecasts, 2018 - 2030
Fig. 55 India market estimates and forecasts, 2018 - 2030
Fig. 56 Australia market estimates and forecasts, 2018 - 2030
Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
Fig. 62 Argentina market estimates and forecasts, 2018 - 2030
Fig. 63 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 65 South Africa market estimates and forecasts, 2018 - 2030
Fig. 66 UAE market estimates and forecasts, 2018 - 2030
Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030

Companies Mentioned

  • Alere Inc.
  • Abbott.
  • Bristol-Myers Squibb Company
  • Janssen Global Service, LLC
  • Gilead Sciences, Inc.
  • Merck & Co. Inc.
  • VIIV Healthcare
  • BD
  • Beckman Coulter, Inc.
  • Sysmex Europe SE
  • Apogee Flow Systems
  • Point Care Technologies Inc.
  • Mylan N.V.
  • F. Hoffman-La Roche Ltd.
  • Siemens Healthcare GmbH
  • QIAGEN.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 985.7 Million
Forecasted Market Value ( USD ) by 2030 $ 1550.17 Million
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

HIV Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

HIV Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
HIV/AIDS Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

HIV/AIDS Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Hiv- Aids Testing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Hiv- Aids Testing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 154 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 226 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 - Product Image

Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

  • Report
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.